These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

161 related items for PubMed ID: 37400875

  • 1. Effect of static magnetic field therapy on diabetic neuropathy and quality of life: a double-blind, randomized trial.
    Nazeri A, Mohammadpour A, Modaghegh MS, Kianmehr M.
    Diabetol Metab Syndr; 2023 Jul 04; 15(1):148. PubMed ID: 37400875
    [Abstract] [Full Text] [Related]

  • 2. Acetyl-L-carnitine for the treatment of diabetic peripheral neuropathy.
    Rolim LC, da Silva EM, Flumignan RL, Abreu MM, Dib SA.
    Cochrane Database Syst Rev; 2019 Jun 15; 6(6):CD011265. PubMed ID: 31201734
    [Abstract] [Full Text] [Related]

  • 3. 10.6-μm infrared laser as adjuvant therapy for diabetic peripheral neuropathy: study protocol for a double-blind, randomized controlled trial.
    Lin L, Chen Y, Li Y, Cheng K, Deng H, Lu J, Zhao L, Shen X.
    Trials; 2022 Jan 18; 23(1):53. PubMed ID: 35042552
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Static magnetic field therapy for symptomatic diabetic neuropathy: a randomized, double-blind, placebo-controlled trial.
    Weintraub MI, Wolfe GI, Barohn RA, Cole SP, Parry GJ, Hayat G, Cohen JA, Page JC, Bromberg MB, Schwartz SL, Magnetic Research Group.
    Arch Phys Med Rehabil; 2003 May 18; 84(5):736-46. PubMed ID: 12736891
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Oral Alpha Lipoic Acid Treatment for Symptomatic Diabetic Peripheral Neuropathy: A Randomized Double-Blinded Placebo-Controlled Study.
    El-Nahas MR, Elkannishy G, Abdelhafez H, Elkhamisy ET, El-Sehrawy AA.
    Endocr Metab Immune Disord Drug Targets; 2020 May 18; 20(9):1531-1534. PubMed ID: 32370731
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Herbal medicine foot bath for the treatment of diabetic peripheral neuropathy: protocol for a randomized, double-blind and controlled trial.
    Fan G, Huang H, Lin Y, Zheng G, Tang X, Fu Y, Wei H, Zhao L, Liu Z, Wang M, Wang S, Li Q, Fang Z, Zhou Y, Dai F, Qiu X.
    Trials; 2018 Sep 10; 19(1):483. PubMed ID: 30201043
    [Abstract] [Full Text] [Related]

  • 13. Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus: a randomized controlled trial.
    Backonja M, Beydoun A, Edwards KR, Schwartz SL, Fonseca V, Hes M, LaMoreaux L, Garofalo E.
    JAMA; 1998 Dec 02; 280(21):1831-6. PubMed ID: 9846777
    [Abstract] [Full Text] [Related]

  • 14. The effects of intradermal botulinum toxin type a injections on pain symptoms of patients with diabetic neuropathy.
    Ghasemi M, Ansari M, Basiri K, Shaigannejad V.
    J Res Med Sci; 2014 Feb 02; 19(2):106-11. PubMed ID: 24778662
    [Abstract] [Full Text] [Related]

  • 15. Effect of an educational booklet for prevention and treatment of foot musculoskeletal dysfunctions in people with diabetic neuropathy: the FOotCAre (FOCA) trial II, a study protocol of a randomized controlled trial.
    Silva EQ, Suda EY, Santos DP, Veríssimo JL, Ferreira JSSP, Cruvinel Júnior RH, Monteiro RL, Sartor CD, Sacco ICN.
    Trials; 2020 Feb 13; 21(1):180. PubMed ID: 32054510
    [Abstract] [Full Text] [Related]

  • 16. The association between pulse wave velocity and peripheral neuropathy in patients with type 2 diabetes mellitus.
    Tentolouris A, Eleftheriadou I, Grigoropoulou P, Kokkinos A, Siasos G, Ntanasis-Stathopoulos I, Tentolouris N.
    J Diabetes Complications; 2017 Nov 13; 31(11):1624-1629. PubMed ID: 28893495
    [Abstract] [Full Text] [Related]

  • 17. Prevalence and impact on quality of life of peripheral neuropathy with or without neuropathic pain in type 1 and type 2 diabetic patients attending hospital outpatients clinics.
    Van Acker K, Bouhassira D, De Bacquer D, Weiss S, Matthys K, Raemen H, Mathieu C, Colin IM.
    Diabetes Metab; 2009 Jun 13; 35(3):206-13. PubMed ID: 19297223
    [Abstract] [Full Text] [Related]

  • 18. A randomized controlled trial assessing the safety and efficacy of palmitoylethanolamide for treating diabetic-related peripheral neuropathic pain.
    Pickering E, Steels EL, Steadman KJ, Rao A, Vitetta L.
    Inflammopharmacology; 2022 Dec 13; 30(6):2063-2077. PubMed ID: 36057884
    [Abstract] [Full Text] [Related]

  • 19. Prevalence and clinical characteristics of restless legs syndrome in diabetic peripheral neuropathy: comparison with chronic osteoarthritis.
    Cho YW, Na GY, Lim JG, Kim SH, Kim HS, Earley CJ, Allen RP.
    Sleep Med; 2013 Dec 13; 14(12):1387-92. PubMed ID: 24210603
    [Abstract] [Full Text] [Related]

  • 20. Disease-specific quality of life in patients with diabetic neuropathy.
    Alghamdi M, Owolabi LF, Adamu B, Taura MG, Jibo A, Almansour M, Alaklabi SN, Alghamdi MA, Imam IA, Abdelrazak R, Rafaat A, Aliyu MH.
    Saudi Med J; 2022 Apr 13; 43(4):408-417. PubMed ID: 35414620
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.